153 related articles for article (PubMed ID: 18186519)
1. Rapid identification of somatic mutations in colorectal and breast cancer tissues using mismatch repair detection (MRD).
Bentivegna S; Zheng J; Namsaraev E; Carlton VE; Pavlicek A; Moorhead M; Siddiqui F; Wang Z; Lee L; Ireland JS; Suyenaga K; Willis TD; Faham M; Seymour AB
Hum Mutat; 2008 Mar; 29(3):441-50. PubMed ID: 18186519
[TBL] [Abstract][Full Text] [Related]
2. PIK3CA gene mutations in breast carcinoma in Malaysian patients.
Ching-Shian Leong V; Jabal MF; Leong PP; Abdullah MA; Gul YA; Seow HF
Cancer Genet Cytogenet; 2008 Dec; 187(2):74-9. PubMed ID: 19027487
[TBL] [Abstract][Full Text] [Related]
3. Genome-wide mutational analyses of breast and colorectal cancers.
Lin J; Sjöblom T
Discov Med; 2007 Feb; 7(37):13-9. PubMed ID: 17343800
[TBL] [Abstract][Full Text] [Related]
4. Genetic and epigenetic analysis of the putative tumor suppressor km23 in primary ovarian, breast, and colorectal cancers.
Campbell IG; Phillips WA; Choong DY
Clin Cancer Res; 2006 Jun; 12(12):3713-5. PubMed ID: 16778097
[TBL] [Abstract][Full Text] [Related]
5. Somatic mutations of the mitochondrial genome in human breast cancers.
Tseng LM; Yin PH; Yang CW; Tsai YF; Hsu CY; Chi CW; Lee HC
Genes Chromosomes Cancer; 2011 Oct; 50(10):800-11. PubMed ID: 21748819
[TBL] [Abstract][Full Text] [Related]
6. Highly efficient somatic-mutation identification using Escherichia coli mismatch-repair detection.
Peters BA; Kan Z; Sebisanovic D; Pujara K; Wang Z; Hong P; Chow B; Stinson J; Carlton VE; Pham TQ; Stern H; Waring P; Hillan KJ; Eberhard DA; de Sauvage F; Zheng J; Faham M; Seshagiri S
Nat Methods; 2007 Sep; 4(9):713-5. PubMed ID: 17704782
[TBL] [Abstract][Full Text] [Related]
7. Comprehensive scanning of somatic mitochondrial DNA mutations in breast cancer.
Tan DJ; Bai RK; Wong LJ
Cancer Res; 2002 Feb; 62(4):972-6. PubMed ID: 11861366
[TBL] [Abstract][Full Text] [Related]
8. PIK3CA cancer mutations display gender and tissue specificity patterns.
Benvenuti S; Frattini M; Arena S; Zanon C; Cappelletti V; Coradini D; Daidone MG; Pilotti S; Pierotti MA; Bardelli A
Hum Mutat; 2008 Feb; 29(2):284-8. PubMed ID: 18022911
[TBL] [Abstract][Full Text] [Related]
9. Selecting patients with young-onset colorectal cancer for mismatch repair gene analysis.
Walker M; O'Sullivan B; Perakath B; Taniere P; Cruger D; Morton D
Br J Surg; 2007 Dec; 94(12):1567-71. PubMed ID: 17665423
[TBL] [Abstract][Full Text] [Related]
10. The continuing search for cancer-causing somatic mutations.
Dalgliesh GL; Futreal PA
Breast Cancer Res; 2007; 9(1):101. PubMed ID: 17319975
[TBL] [Abstract][Full Text] [Related]
11. Prediction of Lynch syndrome in consecutive patients with colorectal cancer.
Green RC; Parfrey PS; Woods MO; Younghusband HB
J Natl Cancer Inst; 2009 Mar; 101(5):331-40. PubMed ID: 19244167
[TBL] [Abstract][Full Text] [Related]
12. Detection of mitochondrial DNA mutations in primary breast cancer and fine-needle aspirates.
Parrella P; Xiao Y; Fliss M; Sanchez-Cespedes M; Mazzarelli P; Rinaldi M; Nicol T; Gabrielson E; Cuomo C; Cohen D; Pandit S; Spencer M; Rabitti C; Fazio VM; Sidransky D
Cancer Res; 2001 Oct; 61(20):7623-6. PubMed ID: 11606403
[TBL] [Abstract][Full Text] [Related]
13. May the APC gene somatic mutations in tumor tissues influence the clinical features of Chinese sporadic colorectal cancers?
Liu X; Shan X; Friedl W; Uhlhaas S; Propping P; Li J; Wang Y
Acta Oncol; 2007; 46(6):757-62. PubMed ID: 17653897
[TBL] [Abstract][Full Text] [Related]
14. Mutational profiling of cancer candidate genes in glioblastoma, melanoma and pancreatic carcinoma reveals a snapshot of their genomic landscapes.
Bleeker FE; Lamba S; Rodolfo M; Scarpa A; Leenstra S; Vandertop WP; Bardelli A
Hum Mutat; 2009 Feb; 30(2):E451-9. PubMed ID: 19058223
[TBL] [Abstract][Full Text] [Related]
15. Novel somatic and germline mutations in cancer candidate genes in glioblastoma, melanoma, and pancreatic carcinoma.
Balakrishnan A; Bleeker FE; Lamba S; Rodolfo M; Daniotti M; Scarpa A; van Tilborg AA; Leenstra S; Zanon C; Bardelli A
Cancer Res; 2007 Apr; 67(8):3545-50. PubMed ID: 17440062
[TBL] [Abstract][Full Text] [Related]
16. Clinicopathological analysis of colorectal cancers with PIK3CA mutations in Middle Eastern population.
Abubaker J; Bavi P; Al-Harbi S; Ibrahim M; Siraj AK; Al-Sanea N; Abduljabbar A; Ashari LH; Alhomoud S; Al-Dayel F; Uddin S; Al-Kuraya KS
Oncogene; 2008 Jun; 27(25):3539-45. PubMed ID: 18193083
[TBL] [Abstract][Full Text] [Related]
17. NOEY2 mutations in primary breast cancers and breast hyperplasia.
Yang J; Hu A; Wang L; Li B; Chen Y; Zhao W; Xu W; Li T
Breast; 2009 Jun; 18(3):197-203. PubMed ID: 19482475
[TBL] [Abstract][Full Text] [Related]
18. Functional analysis of HNPCC-related missense mutations in MSH2.
Lützen A; de Wind N; Georgijevic D; Nielsen FC; Rasmussen LJ
Mutat Res; 2008 Oct; 645(1-2):44-55. PubMed ID: 18822302
[TBL] [Abstract][Full Text] [Related]
19. Comment on "The consensus coding sequences of human breast and colorectal cancers".
Rubin AF; Green P
Science; 2007 Sep; 317(5844):1500. PubMed ID: 17872429
[TBL] [Abstract][Full Text] [Related]
20. Urokinase-type plasminogen activator is a marker of aggressive phenotype and an independent prognostic factor in mismatch repair-proficient colorectal cancer.
Minoo P; Baker K; Baumhoer D; Terracciano L; Lugli A; Zlobec I
Hum Pathol; 2010 Jan; 41(1):70-8. PubMed ID: 19740518
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
